Ad
related to: Pfizer
Search results
AstraZeneca Just Massively One-Upped Pfizer. Here's What It Means for the Stock | The Motley Fool
The Motley Fool· 14 hours agoAs two of the world's largest and most prolific drugmakers, Pfizer (PFE -1.70%) and AstraZeneca (AZN...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 8 hours agoPfizer stock is lingering just above its 50-day line after the company beat first-quarter sales...
Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to...
Pfizer Initiates Multi-Year Cost Reduction Plan Targeting $1.5B Savings By 2027 - Pfizer (NYSE:PFE)
Benzinga· 7 days agoPfizer Inc. PFE has launched a multi-year cost-cutting initiative aimed at saving approximately $1.5...
Pfizer rolls out another cost-cutting program, sets $1.5 billion target by 2027
Reuters· 7 days ago, opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5...
How Much Will Pfizer Pay Out in Dividends This Year?
Motley Fool via Yahoo Finance· 4 days agoA vaccine and an antiviral treatment for COVID-19 made Pfizer (NYSE: PFE) a household name in recent years, but this isn't all the company sells. There...
Pfizer (PFE) Starts Another Cost-Cut Plan to Save $1.5B by 2027
Zacks via Yahoo Finance· 7 days agoThis is the second cost-reduction program undertaken by Pfizer (PFE) in the past year. The first...
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
Motley Fool via Yahoo Finance· 5 days agoNot every high-yield stock will suffer this fate, though. Here is one that likely won't: Pfizer...
Pfizer Files Flurry of Lawsuits Over Migraine Medication Patent | Delaware Law Weekly
Law.com· 1 day agoPfizer recently filed at least seven lawsuits in federal court seeking to enjoin multiple multinational pharmaceutical companies from selling a generic version of its medication ...
Equities Analysts Issue Forecasts for Pfizer Inc.’s Q3 2025 Earnings (NYSE:PFE)
ETF DAILY NEWS· 5 days agoPfizer Inc. (NYSE:PFE – Free Report) – Stock analysts at Zacks Research dropped their Q3 2025 EPS estimates for Pfizer in a research report issued on Wednesday ...